-
Taxonomy & unit
-
ratio: %
-
Description
-
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
-
Summary
-
CRISPR Therapeutics AG quarterly/annual Return On Assets history and growth rate from 2017 to 2024.
- CRISPR Therapeutics AG Return On Assets for the quarter ending December 31, 2024 was -15.8 %, a 125% decline year-over-year.
- CRISPR Therapeutics AG annual Return On Assets for 2024 was -15.8 %, a 125% decline from 2023.
- CRISPR Therapeutics AG annual Return On Assets for 2023 was -7.02 %, a 73.9% increase from 2022.
- CRISPR Therapeutics AG annual Return On Assets for 2022 was -26.9 %, a 286% decline from 2021.
Return On Assets, Annual (%)
Return On Assets, YoY Annual Growth (%)